For T cell lymphoma, anti-PD-1 antibodies have shown modest efficacy in r/r PTCL, but results were limited by a small sample size and concerns of rapid disease progression [26, 27]. Here, PDCD1 is linked to T-cell non-Hodgkin lymphoma.